Suchergebnisse - "Ling, John"

PubPharm (70)

1

Oral PD-L1 inhibitor GS-4224 selectively engages PD-L1 high cells and elicits pharmacodynamic responses in patients with advanced solid tumors

enthalten in: Journal for immunotherapy of cancer | 2024

von Odegard, J. | Othman, A. | Lin, K. | +10

2

Pharmacokinetics of long-acting lenacapavir in participants with hepatic or renal impairment

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Jogiraju, V. | Weber, E. | Hindman, J. | +6

3

Pharmacokinetics, Disposition, and Biotransformation of [14C]Lenacapavir, a Novel, First-in-Class, Selective Inhibitor of HIV-1 Capsid Function, in Healthy Participants Following a Single Intravenous Infusion

enthalten in: Clinical pharmacokinetics | 2024

von Weber, E. | Subramanian, R. | Rowe, W. | +9

4

Pharmacokinetics, Disposition, and Biotransformation of [14C]Lenacapavir, a Novel, First-in-Class, Selective Inhibitor of HIV-1 Capsid Function, in Healthy Participants Following a Single Intravenous Infusion

enthalten in: Clinical pharmacokinetics | 2024

von Weber, E. | Subramanian, R. | Rowe, W. | +9

5

Experience of sudden sensorineural hearing loss following a mild COVID-19 infection

enthalten in: BMJ case reports | 2023

von Gibson, K. | Ling, J. | Peters, M.

6

Human and nonclinical disposition of [14C]bictegravir, a potent integrase strand-transfer inhibitor for the treatment of HIV-1 infection

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2022

von Subramanian, R. | Ling, J. | Wang, J. | +8

7

Human and nonclinical disposition of [14C]bictegravir, a potent integrase strand-transfer inhibitor for the treatment of HIV-1 infection

enthalten in: Xenobiotica | 2022

von Subramanian, R. | Ling, J. | Wang, J. | +8

8

Myers-Briggs Type Indicator Personality Types of Ophthalmology Residents

enthalten in: Journal of academic ophthalmology (2017) | 2021

von Haidar, M. | Ridha, F. | Ling, J. | +5

9

Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor

enthalten in: Clinical pharmacokinetics | 2021

von Humeniuk, R. | Mathias, A. | Kirby, B. | +9

10

Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor

enthalten in: Clinical pharmacokinetics | 2021

von Humeniuk, R. | Mathias, A. | Kirby, B. | +9

1
2
3
4
5
6
7
Nächster »
[7]